![](https://media.bizj.us/view/img/11360978/sarma2*1200xx2509-1413-0-105.jpg)
Philadelphia biotech firm backed by more than $130M names new CEO
A Philadelphia biotechnology company founded seven years ago by two former Johnson & Johnson executives has a new leader. Susan Dillon has stepped down as president and CEO of Aro Biotherapeutics. She will continue as chair of the board and as an …